VIVUS, Inc. (VVUS) financial statements (2021 and earlier)

Company profile

Business Address 900 E. HAMILTON AVENUE
CAMPBELL, CA 95008
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:33112227270242300343
Cash and cash equivalents333066859583103
Short-term investments 81160185146216240
Other undisclosed cash, cash equivalents, and short-term investments 01100 
Receivables222612991212
Inventory, net of allowances, customer advances and progress billings34231816143449
Inventory34231816143449
Prepaid expense3211129
Deferred costs    111
Other undisclosed current assets555681010
Total current assets:97168263303275358424
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset1
Property, plant and equipment0011112
Deferred costs    235
Other noncurrent assets    341
Other undisclosed noncurrent assets12013412 (1)(2)
Total noncurrent assets:12213522676
Other undisclosed assets     12
TOTAL ASSETS:218302265306281367432
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities40423220233538
Accounts payable8910571011
Accrued liabilities32332116161724
Employee-related liabilities     43
Interest and dividends payable     3 
Deferred revenue1
Debt184 591610 
Restructuring reserve     3
Liability for uncertainty in income taxes      0
Deferred revenue and credits219221917
Other undisclosed current liabilities 1   (10)(4)
Total current liabilities:225433948615752
Noncurrent Liabilities
Long-term debt and lease obligation59294231233219217213
Long-term debt, excluding current maturities59294231233219217213
Finance lease, liability0
Operating lease, liability0
Liabilities, other than long-term debt305781016
Deferred revenue and credits567910
Accounts payable and accrued liabilities 000113
Deferred revenue3
Restructuring reserve     13
Other undisclosed noncurrent liabilities 4   (1)(3)
Total noncurrent liabilities:62299236239227227226
Total liabilities:288342274288288284278
Stockholders' equity
Stockholders' equity attributable to parent(69)(40)(9)18(7)83153
Common stock0000000
Additional paid in capital843841835832829826814
Accumulated other comprehensive income (loss)(0)(0)(1)(1)(0)(0)0
Accumulated deficit(912)(881)(844)(813)(836)(743)(661)
Total stockholders' equity:(69)(40)(9)18(7)83153
TOTAL LIABILITIES AND EQUITY:218302265306281367432

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7065651249511481
Revenue, net651249511481
Cost of revenue
(Cost of Goods and Services Sold)
(16)(15)(17)(11)(30)(36)(15)
Gross profit:545048114667966
Operating expenses(65)(69)(63)(69)(156)(165)(236)
Other undisclosed operating income 151711303615
Operating income (loss):(11)(3)356(60)(51)(155)
Nonoperating expense(21)(33)(33)(32)(33)(33)(20)
Interest and debt expense(0)1(33)(33)(33)  
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes0(1)333333  
Income (loss) from continuing operations before income taxes:(31)(37)(31)23(93)(83)(175)
Income tax expense (benefit)(0)(0)(0)(0)(0)1(0)
Net income (loss):(32)(37)(31)23(93)(83)(175)
Other undisclosed net income attributable to parent      0
Net income (loss) available to common stockholders, diluted:(32)(37)(31)23(93)(83)(174)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(32)(37)(31)23(93)(83)(175)
Comprehensive income (loss):(32)(37)(31)23(93)(83)(175)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent000(0)(0)(0)1
Comprehensive income (loss), net of tax, attributable to parent:(31)(37)(31)23(93)(83)(174)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: